Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Anti-TNF therapies could treat patients with COVID-19-related ARDS
This would reduce COVID-19 mortality, as about 17 of COVID-19 patients develop ARDS, states GlobalData
By facilitating whole-genome sequencing we can help in taking swift treatment decisions
Ashish Kumar, Dubey, COO & Co-Founder, Redcliffe Life Sciences talks about how whole genome sequencing can help in predicting…
DoP issues brief guidelines for bulk drug parks, a detailed one to follow
It has also announced the details of a financial assistance programme, including grant-in-aid to three bulk drug parks with a…
Lonza appoints Pierre-Alain Ruffieux as new CEO
Ruffieux is currently Head of Global Pharma Technical Operations at Roche where he and his 12,000-strong team are responsible for…
Sun Pharma initiates Phase II clinical trial on AQCH as potential treatment for COVID-19
AQCH is the first phytopharmaceutical drug approved for clinical trial by DCGI for COVID-19 and has shown anti-SARS-CoV-2 effects…
Australia’s CSL says to help fund, make vaccine candidate if it proves successful
Early pre-clinical results for the vaccine candidate have shown it produced high levels of antibodies that can neutralise the…
Kappa Bioscience appoints Hidayat Ali as Head of Business Development, South Asia
Prior to joining Kappa, he held a position for SEKISUI Chemical, Japan where he oversaw growth of the synthetic amino acid for…
Bill & Melinda Gates Foundation pledges $1.6 billion to Gavi
Funding secured for Gavi’s next strategic period will help the Alliance reach an additional 300 million children in the world’s…
FDA approves Merck’s antibiotic drug to treat hospital-acquired bacterial pneumonia
The FDA is granting the approval to Merck for the drug, Recarbrio
Novavax gets US defense funding for its COVID-19 vaccine
The US-based company said the deal includes the delivery of 10 million doses of its COVID-19 vaccine - NVX‑CoV2373 - to the DoD…